Rbin-1 is primarily used in biochemical and pharmaceutical research as a selective inhibitor of Rab GTPase signaling pathways. It is instrumental in studying intracellular trafficking processes, particularly the regulation of endosomal transport and membrane dynamics. Due to its ability to disrupt Rab-mediated vesicle formation, Rbin-1 serves as a valuable tool for investigating cellular mechanisms involved in protein sorting, receptor recycling, and organelle biogenesis. Its application extends to cancer research, where modulation of Rab activity can influence tumor cell proliferation and migration. Additionally, Rbin-1 has been utilized in studies exploring potential therapeutic targets in neurodegenerative diseases, where impaired vesicular transport contributes to disease progression.